Patent · US Active

Compositions and methods for binding sphingosine-1-phosphate

US8026342B2 · kind B2 · utility

1Cited by
42References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 24, 2008
Grant dateSep 27, 2011
Priority date
Expiry dateOct 24, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/565
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to anti-S1P agents, for example, humanized monoclonal antibodies, and their uses for detection of S1P or for treatment of diseases and conditions associated with S1P.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.